News & Updates

Show Multimedia Only

Trans fatty acid intake tied to hypertensive disorders of pregnancy

05 Oct 2022

Prepregnancy intakes of total fat, unsaturated fat, and monounsaturated fatty acid (MUFA) do not appear to contribute to hypertensive disorders of pregnancy (HDP), but trans fatty acid (TFA) shows a positive association with HDP, reports a study.

Trans fatty acid intake tied to hypertensive disorders of pregnancy

05 Oct 2022

Bashir catheter shows treatment potential for pulmonary embolism

05 Oct 2022 by

Pharmacomechanical catheter-directed thrombolysis (PM-CDT) using the Bashir endovascular catheter demonstrated potential for the treatment of intermediate-risk acute pulmonary embolism (PE), findings from the RESCUE* trial have shown.

Bashir catheter shows treatment potential for pulmonary embolism

05 Oct 2022

Tirzepatide confers renal protection in patients with T2D

05 Oct 2022 by

Once-weekly injection of tirzepatide, a dual GIP and GLP-1 receptor antagonist, slowed eGFR* decline and reduced UACR** in patients with type 2 diabetes (T2D) who are at high risk of cardiovascular (CV) disease compared with once-daily insulin glargine (iGlar), according to a prespecified post hoc analysis of the SURPASS-4*** trial presented at EASD 2022.

Tirzepatide confers renal protection in patients with T2D

05 Oct 2022

Aspirin prevents CVD in older adults with elevated lipoprotein(a) genotypes

04 Oct 2022

Use of aspirin offers health benefits to older individuals with elevated lipoprotein(a) genotypes by preventing cardiovascular events, suggests a study.

Aspirin prevents CVD in older adults with elevated lipoprotein(a) genotypes

04 Oct 2022

Dapagliflozin DELIVERs across full HF spectrum regardless of LVEF

04 Oct 2022 by

The selective, oral sodium–glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin reduces the risk of cardiovascular (CV) death or worsening heart failure (HF) in patients with HF and mildly reduced or preserved ejection fraction (HFmrEF or HFpEF) in the phase III DELIVER* trial, touted as the largest and most inclusive thus far in this patient group.

Dapagliflozin DELIVERs across full HF spectrum regardless of LVEF

04 Oct 2022

Hearts donated after circulatory vs brain death tied to post-transplant dysfunction

03 Oct 2022

Utilization of hearts donated after circulatory death (DCD) appears to result in transient post-transplant right heart dysfunction and short-term clinical outcomes otherwise comparable to transplantation using hearts donated after brain death (DBD), reveals a recent study.

Hearts donated after circulatory vs brain death tied to post-transplant dysfunction

03 Oct 2022

Reproductive factors implicated in atrial fibrillation risk in women

03 Oct 2022

Reproductive factors such as irregular menstrual cycles, nulliparity, and multiparity contribute to an increased risk of new-onset atrial fibrillation in women, as reported in a study.

Reproductive factors implicated in atrial fibrillation risk in women

03 Oct 2022

Use of RAS inhibitors associated with lower cancer risk in T2D

03 Oct 2022 by

A real-world study of over 250,000 type 2 diabetes (T2D) patients from Hong Kong has found that use of renin-angiotensin-system inhibitors (RASIs) is independently associated with reduced risk of cancer, including diabetes-related cancers and cancer-specific mortality in diabetes.

Use of RAS inhibitors associated with lower cancer risk in T2D

03 Oct 2022

Alcohol consumption ups risk of CVD, all-cause mortality in men

01 Oct 2022

Recent evidence suggests that drinking alcoholic beverages is associated with cardiovascular diseases (CVD), including coronary artery disease (CAD), and all-cause mortality.

Alcohol consumption ups risk of CVD, all-cause mortality in men

01 Oct 2022

$Calf vein thrombosis ups 30-day death risk in older adults with hip fractures$

Calf vein thrombosis ups 30-day death risk in older adults with hip fractures

01 Oct 2022

Among older adults suffering from hip fractures, calf deep vein thrombosis (DVT) appears to significantly aggravate the risk of 30-day all-cause mortality, a recent study has found. However, no such effect exists for the 90-day death risk.

Calf vein thrombosis ups 30-day death risk in older adults with hip fractures

01 Oct 2022

News & Updates

Showing Cardiology articles

Showing

Specialty:

Trans fatty acid intake tied to hypertensive disorders of pregnancy

Trans fatty acid intake tied to hypertensive disorders of pregnancy

Bashir catheter shows treatment potential for pulmonary embolism

Bashir catheter shows treatment potential for pulmonary embolism

Tirzepatide confers renal protection in patients with T2D

Tirzepatide confers renal protection in patients with T2D

Aspirin prevents CVD in older adults with elevated lipoprotein(a) genotypes

Aspirin prevents CVD in older adults with elevated lipoprotein(a) genotypes

Dapagliflozin DELIVERs across full HF spectrum regardless of LVEF

Dapagliflozin DELIVERs across full HF spectrum regardless of LVEF

Hearts donated after circulatory vs brain death tied to post-transplant dysfunction

Hearts donated after circulatory vs brain death tied to post-transplant dysfunction

Reproductive factors implicated in atrial fibrillation risk in women

Reproductive factors implicated in atrial fibrillation risk in women

Use of RAS inhibitors associated with lower cancer risk in T2D

Use of RAS inhibitors associated with lower cancer risk in T2D

Alcohol consumption ups risk of CVD, all-cause mortality in men

Alcohol consumption ups risk of CVD, all-cause mortality in men

Calf vein thrombosis ups 30-day death risk in older adults with hip fractures

Calf vein thrombosis ups 30-day death risk in older adults with hip fractures